Own stem cells Gene-Hacked to fight rare hurler syndrome

NCT ID NCT03488394

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study tests a one-time gene therapy for children with Hurler syndrome, a severe genetic disorder. Doctors take the child's own blood stem cells, add a working copy of the missing gene, and put them back. The goal is to help the body produce the enzyme it lacks, potentially stopping disease damage. The trial checks safety and whether the treatment works in up to 8 children aged 28 days to 11 years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUCOPOLYSACCHARIDOSIS IH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hurler syndrome Mucopolysaccharidosis I

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ospedale San Raffaele

    Milan, 20132, Italy